JP2010513901A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010513901A5 JP2010513901A5 JP2009542216A JP2009542216A JP2010513901A5 JP 2010513901 A5 JP2010513901 A5 JP 2010513901A5 JP 2009542216 A JP2009542216 A JP 2009542216A JP 2009542216 A JP2009542216 A JP 2009542216A JP 2010513901 A5 JP2010513901 A5 JP 2010513901A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- fragment
- hox
- homeodomain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0625321.5 | 2006-12-19 | ||
| GBGB0625321.5A GB0625321D0 (en) | 2006-12-19 | 2006-12-19 | Cancer biomarker |
| GBGB0719792.4A GB0719792D0 (en) | 2006-12-19 | 2007-10-10 | Cancer biomarkers |
| GB0719792.4 | 2007-10-10 | ||
| PCT/GB2007/004902 WO2008075056A1 (en) | 2006-12-19 | 2007-12-19 | Cancer biomarkers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010513901A JP2010513901A (ja) | 2010-04-30 |
| JP2010513901A5 true JP2010513901A5 (enExample) | 2011-01-27 |
| JP5683108B2 JP5683108B2 (ja) | 2015-03-11 |
Family
ID=39265269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009542216A Expired - Fee Related JP5683108B2 (ja) | 2006-12-19 | 2007-12-19 | 癌バイオマーカー |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8460882B2 (enExample) |
| EP (1) | EP2115472B1 (enExample) |
| JP (1) | JP5683108B2 (enExample) |
| CN (1) | CN101675341B (enExample) |
| AU (1) | AU2007335999B2 (enExample) |
| BR (1) | BRPI0720371B8 (enExample) |
| CA (1) | CA2671939C (enExample) |
| CY (1) | CY1115178T1 (enExample) |
| DK (1) | DK2115472T3 (enExample) |
| ES (1) | ES2445185T3 (enExample) |
| GB (2) | GB0625321D0 (enExample) |
| IL (1) | IL199241A (enExample) |
| MX (1) | MX2009006378A (enExample) |
| NZ (1) | NZ577548A (enExample) |
| PL (1) | PL2115472T3 (enExample) |
| PT (1) | PT2115472E (enExample) |
| RU (1) | RU2460075C2 (enExample) |
| SI (1) | SI2115472T1 (enExample) |
| WO (1) | WO2008075056A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8461126B2 (en) | 2005-10-14 | 2013-06-11 | Phigenix, Inc. | Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions |
| DE102006047617B4 (de) | 2006-10-09 | 2008-11-27 | Clariant International Limited | Verfahren zur Herstellung basischer (Meth)acrylamide |
| DE102008017216B4 (de) | 2008-04-04 | 2013-08-14 | Clariant International Ltd. | Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden |
| GB0823445D0 (en) * | 2008-12-23 | 2009-01-28 | Univ Surrey | Biomarker |
| DE102009031059A1 (de) | 2009-06-30 | 2011-01-05 | Clariant International Ltd. | Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen |
| EP2454597A1 (en) * | 2009-07-13 | 2012-05-23 | The University of Surrey | Therapeutic peptides, polypeptides ans nucleic acid sequences |
| GB0912175D0 (en) * | 2009-07-13 | 2009-08-26 | Univ Surrey | Biomarker |
| GB0912190D0 (en) * | 2009-07-13 | 2009-08-26 | Univ Surrey | Biomarker |
| DE102009042522A1 (de) | 2009-09-22 | 2011-04-07 | Clariant International Ltd. | Kontinuierliches Umesterungsverfahren |
| DE102009042523B4 (de) | 2009-09-22 | 2012-02-16 | Clariant International Ltd. | Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen |
| GB0921329D0 (en) * | 2009-12-04 | 2010-01-20 | Univ Surrey | Biomarker |
| DE102010056565A1 (de) | 2010-12-30 | 2012-07-05 | Clariant International Ltd. | Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere |
| CA2835728A1 (en) * | 2011-05-12 | 2012-11-15 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| US20140106363A1 (en) * | 2011-05-12 | 2014-04-17 | Noviogendix Research B.V. | Molecular markers in prostate cancer |
| WO2013037118A1 (zh) * | 2011-09-16 | 2013-03-21 | 上海长海医院 | 前列腺癌的生物学标志物、治疗靶点及其用途 |
| JP5990274B2 (ja) * | 2011-12-05 | 2016-09-07 | ファイジェニクス インコーポレイテッド | 前立腺病態の処置のためのｅｎ２、ｐａｘ２、および／またはｄｅｆｂ１の標的化 |
| WO2014005138A1 (en) * | 2012-06-29 | 2014-01-03 | Kerschensteiner Daniel A | Colorimetric gelatinase assay |
| US10613087B2 (en) * | 2012-08-10 | 2020-04-07 | Analiza, Inc. | Methods and devices for analyzing species to determine diseases |
| MX2015015452A (es) * | 2013-05-09 | 2016-03-15 | Procter & Gamble | Metodo y sistema para evaluar una condicion de salud. |
| WO2016102560A1 (en) * | 2014-12-23 | 2016-06-30 | The University Of Surrey | Glycosylated biomarker |
| KR101698654B1 (ko) * | 2014-12-24 | 2017-01-20 | 포항공과대학교 산학협력단 | En2에 특이적으로 결합하는 dna 압타머 및 이의 용도 |
| JP6745820B2 (ja) * | 2015-05-29 | 2020-08-26 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 前立腺がん予後判定の方法 |
| CN108289929A (zh) * | 2015-09-23 | 2018-07-17 | 国家科学研究中心 | 用于治疗神经退行性障碍的同源异型蛋白 |
| CN106282347A (zh) * | 2016-08-17 | 2017-01-04 | 中南大学 | HoxC11作为生物标志物在制备肺腺癌的预诊断试剂中的应用 |
| US10508287B2 (en) | 2016-12-28 | 2019-12-17 | Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences | Method for regenerating T cells and applications thereof |
| KR101777085B1 (ko) * | 2017-02-23 | 2017-09-11 | 주식회사 성균바이오텍 | En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물 |
| KR101777259B1 (ko) | 2017-07-14 | 2017-09-13 | 주식회사 무진메디 | En2 단백질을 특이적으로 인식하는 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물 |
| KR101777254B1 (ko) | 2017-07-14 | 2017-09-13 | 주식회사 무진메디 | En2 단백질을 특이적으로 인식하는 특정 항원으로부터 얻어진 단클론 항체 또는 이를 함유하는 전립선암 진단용 조성물 |
| CN107894507A (zh) * | 2017-11-22 | 2018-04-10 | 南宁科城汇信息科技有限公司 | 一种发现和鉴定肝癌血清差异表达蛋白和验证标志物蛋白方法 |
| CN107727729A (zh) * | 2017-11-22 | 2018-02-23 | 南宁科城汇信息科技有限公司 | 一种oa候选标志物诊断模型的建立方法 |
| KR101923199B1 (ko) | 2018-04-25 | 2018-11-28 | 주식회사 무진메디 | 펩스타틴 a를 함유하는 소변 내 en2 진단용 조성물 |
| CN111363817B (zh) * | 2018-12-26 | 2024-02-02 | 广州康立明生物科技股份有限公司 | 基于hoxd12基因的肺癌诊断剂及试剂盒 |
| CN118511077A (zh) | 2021-10-28 | 2024-08-16 | 克利夫兰诊断有限公司 | 用于确定多种类型的癌症的分配系统和方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0996725A1 (en) * | 1997-06-27 | 2000-05-03 | Human Genome Sciences, Inc. | Human nk-3 related prostate specific gene-1 |
| RU2234942C2 (ru) * | 1998-07-14 | 2004-08-27 | Корикса Корпорейшн | Выделенный опухолевый полипептид предстательной железы и кодирующий его полинуклеотид |
| EP1131095A4 (en) * | 1998-10-19 | 2003-04-23 | Diadexus Inc | METHOD FOR DIAGNOSING, MONITORING, CLASSIFYING STAGES, VISUALIZING AND TREATING PROSTATE CANCER |
| US20040029208A1 (en) | 2000-05-30 | 2004-02-12 | Ravn Helle Weber | Assay method and kit for testing biological material for exposure to stress using biomarkers |
| WO2002002807A2 (en) * | 2000-06-30 | 2002-01-10 | Epigenomics Ag | Diagnosis of diseases associated with cell signalling |
| US20050079492A1 (en) * | 2000-09-12 | 2005-04-14 | Burgess Jr. Robert M. | Micro-arrayed organization of transcription factor target genes |
| US20040063216A1 (en) | 2000-12-24 | 2004-04-01 | Iser Lubocki | Method for detecting biomarkers |
| NZ527180A (en) | 2000-12-24 | 2007-02-23 | Iser Lubocki | A method for detecting biomarkers |
| ATE429511T1 (de) * | 2001-03-01 | 2009-05-15 | Epigenomics Ag | Verfahren zur entwicklung von gensätzen zu diagnostischen und therapeutischen zwecken auf grundlage des expressions- und methylierungsstatus der gene |
| US6949342B2 (en) * | 2001-12-21 | 2005-09-27 | Whitehead Institute For Biomedical Research | Prostate cancer diagnosis and outcome prediction by expression analysis |
| CA2469089A1 (en) * | 2003-07-08 | 2005-01-08 | Institut De Recherches Cliniques De Montreal | En-2 gene, disgnostic and therapeutic uses thereof |
| US20060014301A1 (en) | 2004-07-13 | 2006-01-19 | Power3 Medical Products, Inc. | Antibody-based system for detection of differential protein expression patterns |
| EP2311984A1 (en) * | 2004-12-02 | 2011-04-20 | Epigenomics AG | Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders |
| WO2006089091A2 (en) * | 2005-02-18 | 2006-08-24 | Memorial Sloan-Kettering Cancer Center | Methods for detecting minimum residual disease |
-
2006
- 2006-12-19 GB GBGB0625321.5A patent/GB0625321D0/en not_active Ceased
-
2007
- 2007-10-10 GB GBGB0719792.4A patent/GB0719792D0/en not_active Ceased
- 2007-12-19 PL PL07848631T patent/PL2115472T3/pl unknown
- 2007-12-19 NZ NZ577548A patent/NZ577548A/en not_active IP Right Cessation
- 2007-12-19 RU RU2009127774/15A patent/RU2460075C2/ru not_active IP Right Cessation
- 2007-12-19 DK DK07848631.3T patent/DK2115472T3/da active
- 2007-12-19 ES ES07848631.3T patent/ES2445185T3/es active Active
- 2007-12-19 BR BRPI0720371A patent/BRPI0720371B8/pt not_active IP Right Cessation
- 2007-12-19 US US12/518,708 patent/US8460882B2/en active Active
- 2007-12-19 CA CA2671939A patent/CA2671939C/en active Active
- 2007-12-19 CN CN200780051417.9A patent/CN101675341B/zh not_active Expired - Fee Related
- 2007-12-19 JP JP2009542216A patent/JP5683108B2/ja not_active Expired - Fee Related
- 2007-12-19 AU AU2007335999A patent/AU2007335999B2/en not_active Ceased
- 2007-12-19 MX MX2009006378A patent/MX2009006378A/es active IP Right Grant
- 2007-12-19 SI SI200731399T patent/SI2115472T1/sl unknown
- 2007-12-19 EP EP07848631.3A patent/EP2115472B1/en not_active Not-in-force
- 2007-12-19 PT PT78486313T patent/PT2115472E/pt unknown
- 2007-12-19 WO PCT/GB2007/004902 patent/WO2008075056A1/en not_active Ceased
-
2009
- 2009-06-08 IL IL199241A patent/IL199241A/en active IP Right Grant
-
2014
- 2014-02-05 CY CY20141100091T patent/CY1115178T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010513901A5 (enExample) | ||
| RU2009127774A (ru) | Биомаркеры рака | |
| Hudler et al. | Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics | |
| US10345309B2 (en) | Biomarkers for gastric cancer and uses thereof | |
| EP2796878A1 (en) | New biomarkers for diagnosis, prediction and/or prognosis of sepsis and uses thereof | |
| WO2021076036A1 (en) | Apparatuses and methods for detection of pancreatic cancer | |
| JP4916441B2 (ja) | 結腸直腸腺腫及び／又は癌腫に対するバイオマーカーとしてのトランスサイレチンの使用；検出方法及び試験システム | |
| US20220268776A1 (en) | Biomarker panel for diagnosing pancreatic cancer and use thereof | |
| JP6774925B2 (ja) | 性別に基づく疾病の識別・評価・予防及び治療を含む、肺病の識別・評価・予防及び治療のための方法並びにそのキット | |
| TWI408370B (zh) | 胰臟癌之血清生物檢測標誌及其應用 | |
| CN104272112B (zh) | 用于帮助诊断中风的基于生物标记的方法和生物芯片 | |
| JP4516124B2 (ja) | 肝線維症の診断方法 | |
| EP2569451A1 (en) | Methods and devices for diagnosing alzheimers disease | |
| US20130210667A1 (en) | Biomarkers for Predicting Kidney and Glomerular Pathologies | |
| CN108841954A (zh) | 生物标志物在卵巢癌评估中的应用 | |
| KR20140115490A (ko) | 간암 진단용 바이오 마커 | |
| JP2016530545A (ja) | 卵巣がんに関するバイオマーカー | |
| AU2014247083B2 (en) | Methods and arrays for use in biomarker detection for prostate cancer | |
| JP2012526543A5 (enExample) | ||
| US20140248637A1 (en) | Composition for diagnosis of lung cancer and diagnosis kit of lung cancer | |
| KR20230113742A (ko) | 난소암의 검출 및 치료를 위한 방법 | |
| WO2023230584A1 (en) | Methods and systems for risk stratification and management of bladder cancer | |
| KR102136747B1 (ko) | 장형 위암의 예후 진단 마커 | |
| CN106093241A (zh) | 可用于检测喉癌的标志物及其用途 | |
| CN120442791B (zh) | 非功能性胰腺神经内分泌肿瘤预后标志物及其应用 |